Inj Atosiban 37 point 5 mg per 5ml,Cap Nifedipine Retard 20 mg,Dinoprostone Gel 0 point 5mg in 3gm,
Indian Army
JALANDHAR, PUNJAB
Progress
RAQuantity
636
A tender has been published for Dg Armed Forces Medical Service Recombinant Somatropin for Injection 36 IU of 12mg or ml, Tab Mesalamine 1 point 2 gm, Mesalamine Suppository 500 mg, Tab Dehydroepiandrosterone 75 Mg, Tab Abiraterone 250 Mg, Inj Zolendronic Acid 4 Mg in KANNUR, KERALA. Quantity: 636 by. Submission Deadline: 14-06-2025 09: 00: 00. Check eligibility and apply.
Main Document
BOQ
BOQ
GEM_GENERAL_TERMS_AND_CONDITIONS
Indian Army
JALANDHAR, PUNJAB
Border Security Force (bsf)
Indian Air Force
Indian Army
NASHIK, MAHARASHTRA
Indian Army
Tender Results
Loading results...
| Item # | Title | Description | Quantity | Unit | Consignee | Delivery (Days) |
|---|---|---|---|---|---|---|
| 1 | Recombinant Somatropin for Injection 36 IU of 12mg or ml | Patient Care | 5 | pfs | mhcannanore@buyer | 30 |
| 2 | Tab Mesalamine 1 point 2 gm | Patient Care | 180 | no | mhcannanore@buyer | 30 |
| 3 | Mesalamine Suppository 500 mg | Patient Care | 90 | no | mhcannanore@buyer | 30 |
| 4 | Tab Dehydroepiandrosterone 75 Mg | Patient Care | 120 | no | mhcannanore@buyer | 30 |
| 5 | Tab Abiraterone 250 Mg | Patient Care | 240 | no | mhcannanore@buyer | 30 |
| 6 | Inj Zolendronic Acid 4 Mg | Patient Care | 1 | vial | mhcannanore@buyer | 30 |
Start
24-Jun-2025, 2:00 pm
End
25-Jun-2025, 2:00 pm
Duration: 24 hours
Reverse Auction Document
✅ RA concluded. Check financial results for final rankings.
| S.No | Seller | Item | Date | Status |
|---|---|---|---|---|
| 1 | MEDI WORLD Under PMA | - | 13-06-2025 20:32:23 | Qualified |
| 2 | NAINETH ENTERPRISES Under PMA | - | 14-06-2025 07:43:36 | Disqualified |
| 3 | OMANA MEDICAL STORE Under PMA | - | 31-05-2025 11:50:52 | Disqualified |
| 4 | PRANAVAM PHARMACEUTICALS Under PMA | - | 13-06-2025 19:19:02 | Qualified |
| 5 | ZENEUR PHARMACEUTICALS Under PMA | - | 13-06-2025 22:52:32 | Qualified |
| Rank | Seller | Price | Item |
|---|---|---|---|
| L1 | MEDI WORLD(MII) Under PMA | ₹1,29,950 | Item Categories : Recombinant Somatropin for Injection 36 IU of 12mg or ml,Tab Mesalamine 1 point 2 gm,Mesalamine Sup |
| L2 | PRANAVAM PHARMACEUTICALS (MII) Under PMA | ₹1,33,292 | Item Categories : Recombinant Somatropin for Injection 36 IU of 12mg or ml,Tab Mesalamine 1 point 2 gm,Mesalamine Sup |
| L3 | ZENEUR PHARMACEUTICALS (MII) Under PMA | ₹1,53,755 | Item Categories : Recombinant Somatropin for Injection 36 IU of 12mg or ml,Tab Mesalamine 1 point 2 gm,Mesalamine Sup |
Key insights about KERALA tender market
The eligibility requirements for participation in the tender include being a duly registered entity with the capacity to supply medicines and compliance with local and national regulations. This entails possessing relevant licenses, certificates, and demonstrating experience in prior government or institutional supply contracts.
Participants must provide a range of required certificates, including trade licenses, GST registration, and any pharmaceutical-specific accreditations. Submissions should also include quality assurance certificates that confirm adherence to manufacturing standards for medicines.
The registration process for the procurement can be completed through the GEM platform. Interested bidders must create an account, complete the necessary forms, and ensure they provide all required documentation for verification before submission.
All accepted document formats for submission must be electronic as specified in the tender requirements. Common formats include PDF, JPEG for images, and DOC/DOCX for text documents. It is essential to keep file sizes within the specified limits outlined in the tender documentation.
This tender has dedicated provisions to support Micro, Small, and Medium Enterprises (MSEs), offering benefits such as relaxed qualification criteria and competitive pricing preferences. MSE businesses are encouraged to leverage these provisions to participate actively in national procurement initiatives.
Sign up now to access all documents
Main Document
BOQ
BOQ
GEM_GENERAL_TERMS_AND_CONDITIONS